• AMG 487 for Reliable CXCR3 Assays

  2026-09-02

  Learn how AMG 487 (SKU B3266) can help researchers distinguish CXCR3-dependent signaling from nonspecific effects in migration, calcium-flux, macrophage-polarization, and cytotoxicity workflows. The article connects product potency and handling data with state-sensitive findings from a 2024 macrophage study.

• Z-WEHD-FMK: A Translational Lens on Pyroptosis

  2026-09-02

  Z-WEHD-FMK provides a practical way to interrogate inflammatory caspase activity across pyroptosis, infection, and tumor biology. This thought-leadership guide connects the HOXC8–caspase-1 axis in lung cancer with experimental strategy, controls, protocol design, and the limits of pharmacologic interpretation.

• Grazoprevir Hydrate: HCV Assay Workflows

  2026-09-01

  Build reproducible HCV replicon and antiviral-response assays around the picomolar NS3/4A protease inhibitor Grazoprevir hydrate. This guide connects concentration-response design with genotype, combination, resistance, and translational use cases, including HIV/HCV coinfection and renal-disease research.

• DAPI Solution (1 mg/mL) for Reliable Cell Assays

  2026-09-01

  Learn how DAPI Solution (1 mg/mL), SKU K2401, supports nuclear visualization, membrane-integrity assessment, and flow cytometry DNA staining in challenging cell assays. This scenario-based guide separates product specifications from practical optimization and explains how to interpret DAPI alongside mechanistic endpoints.

• HyperScript First-Strand cDNA Synthesis Kit Guide

  2026-08-31

  The HyperScript First-Strand cDNA Synthesis Kit uses engineered HyperScript Reverse Transcriptase for first-strand cDNA synthesis from purified total RNA or poly(A)+ RNA. Its reduced RNase H activity, enhanced thermal stability, primer flexibility, and reported cDNA length of up to 12.3 kb support structured RNA templates and low-abundance transcript workflows.

• Disrupting Tumor pH for Chemo-Immunotherapy

  2026-08-31

  The reference study introduces tumor cell-derived biomimetic microparticles that co-deliver syrosingopine and a pH-responsive doxorubicin prodrug to disrupt both intracellular and extracellular tumor pH homeostasis. Its findings connect lactate-export blockade with enhanced chemotherapy and remodeling of immunosuppressive tumor immunity, offering a useful framework for mechanistic assay design.

• Melatonin, Autophagy, and Hypertrophic Scar Biology

  2026-08-30

  The reference study identifies MT2 receptor-dependent suppression of PI3K/Akt/mTOR signaling as a mechanism by which melatonin enhances autophagy and restrains hypertrophic scar fibroblast activity. Its combination of primary human fibroblast experiments, pathway perturbation, transcriptomics, and rabbit-ear validation provides a useful framework for evaluating antifibrotic mechanisms while highlighting the need to distinguish oxidative-stress signatures from direct causal evidence.

• Dinaciclib Selectively Targets VHL-Deficient CC-RCC

  2026-08-29

  Nelson and colleagues identified a synthetic-lethal relationship between Dinaciclib treatment and loss of the von Hippel–Lindau tumor suppressor in clear cell renal cell carcinoma. Their combination of cell-based assays, mechanistic signaling analysis, and an orthotopic patient-derived xenograft model supports selective targeting of both bulk tumor cells and CD105-positive cancer stem-like cells.

• RITA (NSC 652287): p53 Research Guide

  2026-08-28

  RITA (NSC 652287) is an MDM2-p53 interaction inhibitor for cancer biology research. Product-reported nanomolar activity in renal carcinoma cells and tumor xenograft regression support its use as a research tool, while assay design must distinguish growth inhibition from direct cell killing.

• Vorinostat for HDAC and Apoptosis Assays

  2026-08-28

  Build reproducible cancer-cell workflows with Vorinostat, a soluble-in-DMSO HDAC inhibitor that links histone acetylation to mitochondrial apoptosis. Use dose–response profiling, chromatin readouts, and orthogonal cell-death assays to distinguish transcriptional effects from the execution of apoptosis.

• Spatial Kidney Assembloids for Disease Modeling

  2026-08-27

  Huang et al. developed spatially patterned mouse and human kidney progenitor assembloids that better reproduce nephron–collecting duct organization, maturation, and selected kidney functions than conventional organoids. Their genome-edited PKD2-deficient human assembloids also modeled cystic disease and revealed interactions among cyst epithelium, stroma, and macrophages, providing a more physiologically relevant platform for kidney disease research.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-08-27

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus is a T7 RNA polymerase in vitro transcription kit for producing research-scale RNA transcripts, including modified, labeled, and biotinylated designs. Its product specifications report up to 180 μg of RNA from a 20 μL reaction containing 1 μg of control template.

• Mdivi-1 Workflows for DRP1 and Apoptosis

  2026-08-26

  Mdivi-1 provides a cell-permeable way to test how DRP1-dependent mitochondrial fission contributes to fragmentation, mitochondrial outer membrane permeabilization, and apoptosis. This practical guide connects assay design with ECM-driven mitochondrial remodeling and outlines controls for cell, retina, and mechanistic studies.

• VX-765: From Caspase-1 Mechanism to Translation

  2026-08-26

  A mechanistic and strategic guide to using VX-765 and VRT-043198 for cytokine processing, pyroptosis, cross-caspase selectivity, and translational inflammation research.

• 2-APB and the Next Era of Calcium Signaling

  2026-08-25

  A translational perspective on how 2-APB (2-aminoethoxydiphenyl borate) can separate IP3R-mediated calcium release, TRPC activity, and store-operated calcium entry from the upstream Gαq–PLCβ3 axis highlighted by recent cardiovascular research.

8048 records 1/537 page Next 12345 下5页 Last page